总时间（秒）：12.13
问答时间（秒）：9.48

Here is the extracted and standardized information from the provided literature in JSON format:

```
{
  "Variants Include": [
    {
      "Gene": "Parkin",
      "variants": [
        {
          "HGVS": "NM_006403.3:c.1525C>T",
          "cDNA Change": {
            "transcript": "NM_006403.3",
            "ref": "C",
            "alt": "T",
            "position": "1525"
          },
          "Protein Change": {
            "ref": "L",
            "alt": "S",
            "position": "508"
          },
          "Description in input context": "This mutation disrupts the autoinhibition of Parkin and results in a constitutively active molecule."
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0010346"
  },
  "Experiment Method": [
    {
      "Assay Method": "Western Blot",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "The experiment was conducted using the HEK293 cell line."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_006403.3:c.1525C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "complete loss-of-function",
          "Result Description": "Protein expression was reduced by 90% for the variant NM_006403.3:c.1525C>T."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type cDNA was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Student's t-test was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Protein expression greater than 70%.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Protein expression less than 30%.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}
```

Note that I have followed the provided workflow and extracted the relevant information from the literature. However, please note that some fields may not be applicable or have not been mentioned in the literature (e.g., validation controls for pathogenic/likely pathogenic variants).